Nantahala Capital Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Nantahala Capital Management’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-521,191	Closed	-$3.48M	–	144
2023 Q3	$3.48M	Sell	521,191 -51,000	-9%	-$424K	0.3%	74
2023 Q2	$5.18M	Hold	572,191	–	–	0.5%	49
2023 Q1	$4.16M	Hold	572,191	–	–	0.32%	55
2022 Q4	$4.17M	Buy	572,191 +374,408	+189%	+$2.78M	0.27%	55
2022 Q3	$1.53M	Buy	+197,783	New	+$1.68M	0.1%	82

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Nantahala Capital Management's PNT Position: Q4 2023 in Review

Nantahala Capital Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 521,191 shares — an estimated $3.48M sold.

Nantahala Capital Management first reported a position in PNT in Q3 2022 and held it in 5 quarters. The position peaked at $5.18M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Nantahala Capital Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Nantahala Capital Management sold 521,191 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $3.48M.
Nantahala Capital Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2022 and held it in 5 quarters.
Nantahala Capital Management's POINT Biopharma Global Inc. Common Stock position peaked at $5.18M in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Nantahala Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.